Presentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting

Similar documents
Why is Critical Incident Reporting and Shared Learning Important for Patient Safety?

Global standards and interoperability in Australian healthcare

A MEDICATION SAFETY ACTION PLAN. Produced September 2014

Safe Medication Practices

Reuse of SUDs: Using Evidence to Inform Policy

Medication Bar Code System Implementation Planning

BUSINESS CASE. Implementation of Bar code Medication Administration System at the Sault Area Hospital (SAH)

Re-Engineering Medication Processes to Capitalize on Technology. Jane Englebright, PhD, RN Vice President, Quality HCA

Helping physicians care for patients Aider les médecins à prendre soin des patients

European Association of Hospital Pharmacists (EAHP)

Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery

Medication Safety in LTC. Objectives. About ISMP Canada

Pan-Canadian Public Health Network. Overview Presentation June 2012

Corporate Profile. December 2017

Unit dose requirements

Automation and Information Technology

Introduction of EPMA in paediatric practice in UK:

Breakfast With the Chiefs December 15, 2005 Philip Hassen, CEO, CPSI

Canada s Multi-Stakeholder Approach to Drug Shortages

D DRUG DISTRIBUTION SYSTEMS

Population. 4.1 million People Maori 14% Pacific People 6% Asian 6% 39.9 million sheep

MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY. April 2009 September 2012

COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE)

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS

How BPOC Reduces Bedside Medication Errors White Paper

17/06/2014. Clinicians Driving Technology - Developing ST CPOE Practice Guidelines and Supporting Their Adoption. Objectives. Cancer Care Ontario

Medical Assistance in Dying

An Overview of Sterile Compounding. Marshall Moleschi, Registrar Ontario College of Pharmacists

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM)

Canadian Hospital Experiences Survey Frequently Asked Questions

Alaris Products. Protecting patients at the point of care

I CSHP 2015 CAROLYN BORNSTEIN

The Role of the Agency for Healthcare Research and Quality (AHRQ) in the US Drug Safety System

Advancing Digital Health in Canada

Hospital and Other Healthcare Facilities

Policy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription.

Pharmacy Services - Homes for the Aged

Report of the Task Force on Manpower Shortage

Title of Case Study: Reduce medication errors with closed-loop medication administration system Leslie St. Toronto, ON M2K 1E1, Canada

C DRUG DISTRIBUTION SYSTEMS

Improving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)

ONE ID Alternative Registry Standard. Version: 1.0 Document ID: 1807 Owner: Senior Director, Integrated Solutions & Services

COMPUS Procedure Evidence-Based Best Practice Recommendations

Health Technology Review Business Case Template

Modernizing Hospital Adverse Event Reporting

Traceability of Drugs: Implementation in a hospital pharmacy in Argentina

The Scope of the Medication Error Problem

Technologies in Pharmacology

How can the labelling and the packaging of drugs impact on drug safety? Prof. Pascal BONNABRY. Head of pharmacy. Swissmedic, Bern, June 19, 2007

Drug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06

Evolution of Medicare. 28/Nov/12. Canadian Health Care System 101. Outline. How has Medicare evolved over time?

Building a healthy legacy together. Presentation by Shelley Lipon, Executive Regional Director, Canada Health Infoway to ICTAM October 28, 2009

Patient Safety: 10 Years Later Why is Improvement So Hard? Patient Safety: Strong Beginnings

Background and Methodology

Filling the Prescription The case for pharmacare now

EMR Adoption: Benefits Realization

Impact of Hospital Pharmacists on Patient Safety

FRAMEWORK FOR PHARMACIST PRESCRIBING IN BRITISH COLUMBIA. February Framework_Pharmacist_Prescriber v (Revised )

Prescribing Standards for Nurse Practitioners (NPs)

Methodology Notes. Cost of a Standard Hospital Stay: Appendices to Indicator Library

CASE-BY-CASE REVIEW PROGRAM (CBCRP) CASE-BY-CASE REVIEW POLICY FOR CANCER DRUGS

to the New Practice Framework

Quality Improvement Plan (QIP) Narrative for Health Care Organizations in Ontario

FACT SHEET. The Launch of the World Alliance For Patient Safety " Please do me no Harm " 27 October 2004 Washington, DC

Medical Assistance in Dying

Nova Scotia Public Reporting Serious Patient Safety events? Advancing Patient Safety & Quality?

FINAL STATUS DOCUMENT

The Assessment of Postoperative Vital Signs: Clinical Effectiveness and Guidelines

IMPACT OF TECHNOLOGY ON MEDICATION SAFETY

Delivering the Five Year Forward View Personalised Health and Care 2020

Proposed amendments to the Marihuana for Medical Purposes Regulations

Optimizing Patient Care Transitions

REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY

Most of you flew to this meeting

Accreditation of Hospital Pharmacies Update

Position Statement. The Role of the Registered Nurse in Health Informatics

E-Health System and EHR. Health and Wellness Atlantic Access and Privacy Workshop June 27-28, 2005

Overview. Improving Safety with Health Information Technology. Prioritizing Safety. Question 22/10/2013

Impact of an Innovative ADC System on Medication Administration

E Prescribing E Rx: Background. E Rx: Definition. Rebecca H. Wartman, O.D.

SAFE Standard of Care

REQUEST FOR PROPOSAL

Benefits Evaluation Experiences at Canada Health Infoway

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

Clinical. Prescribing Medicines SOP. Document Control Summary. Contents

MedChart. Electronic medication management. reducing medication errors, improving patient outcomes

Measuring Harm. Objectives and Overview

Patient Safety Research Introductory Course Session 3. Measuring Harm

MedChart Electronic Medication Management. A clear path to benefits realisation

Guidance for Medication Reconciliation and System Integration Process

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Planning to Improve the Health of a Diverse Population

Reducing Medication Errors

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003

INQUEST INTO THE DEATH OF: MARIE TANNER

End-to-end infusion safety. Safely manage infusions from order to administration

Evaluation of The Health Council of Canada (HCC)

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

Preventing Adverse Drug Events and Harm

Transcription:

Presentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting Gatineau, Quebec June 10, 2011 (Amended for Project Web Page)

Canadian Pharmaceutical Bar Coding Project Improved Medication Safety Moving Forward A National Collaborative FPT Deputy Ministers of Health Meeting June 10, 2011

What s the Adverse Drug Event Problem? The number of Adverse Drug Events (ADEs) is unacceptably high (3-6% of admissions to hospitals). Medication errors reported in a 2007 CIHI report: 10% Canadian patients report experiencing a medication error in the previous two year period. (Commonwealth Fund Health Policy Survey, 2005) Medication safety has become an area of increasing awareness. Of reported ADEs: - Serious patient injury or deaths, results in 20-30% of events. - The more serious the ADE, the more likely the event was preventable. - Overall 30-40% of ADEs are preventable medication errors. - Many ADEs are caused by human error. - Errors occur at each stage of the medication process

What s the cost impact of ADEs? Baker Norton Canadian Adverse Event Study (2004) * The overall annual number of all adverse events is 185,000 and 70,000 are potentially preventable. * 24% of Adverse Events were related to medication or fluid errors. * The Mean Increased Length of Stay related to an AE was; - For small hospitals: 7.7 days - For Large hospitals: 3.6 days - For Teaching hospitals: 6.2 days Note: Morbidity and cost on ambulatory, residential or home care errors has not been well studied in Canada, but has been found to be equally significant in U.S. studies.

Where Can Bar Coding Help? System Sources of Errors: Leap LL, Bates, DW. et al, JAMA 1995 Measured Human Interception Rates 49% of Errors

Effectiveness of Bar Code (AI) in Safety (Examples of Effectiveness) A 63% reduction pharmacy dispensing. Study shows a return of Investment of approximately 1 year. Maviglia SM, Churchill, Wm et al. Arch Intern Med. 2007; 167: 788-794 A 41.4 % reduction in dose administration and order transcriptions, excluding potential timing errors. A 27.3% reduction in dose timing errors. Barcode technology is an integral piece of safe medication management systems like Electronic Health Records (EHR) and medication reconciliation. Poon EG, et al. New England Journal of Medicine 2010; 362:1698-707 A 54% reduction in dose administration errors with bar coding with Electronic Medication Records. Paoletti R et al. American Journal of Health-Systems Pharmacists. 2007; 64(5): 536-543

What s the situation in Canada? Medication Practice Situation in Canada, as of 2009 Many primary (e.g. vial) and secondary (outer package) labels did not have a bar code. There were no national standards for the type of bar code to use, nor the required information within the code itself. Reader/scanners and software cannot be seamlessly written to read the codes. There were no national standards for the rules regarding how to assign a global identification number, which is used continuously through the medication chain, and at every package level, nor a common product descriptor database connected to such bar codes. Bar codes, when applied were different between hospitals and community, and often between healthcare provider sites.

Collaborating Organizations Canadian Pharmaceutical Bar Coding Project: Setting competing interests aside

Project Overview A National Collaboration between six healthcare sectors. Major Objectives: * To develop a sustainable pan-canadian strategy for bar coding of marketed pharmaceutical products. * To select a common product database for standardized product descriptor data. * To encourage clinical information systems development which utilize automated identification and data capture at each point of the medication chain. * To create a national environment for the implementation of aligned automated identification practices within each identified healthcare sector.

National Advisory Partners Public Health Agency of Canada (reciprocal Project lead for Canadian vaccine project) Canada Health Infoway Canadian Nurses Association Canadian Society of Hospital Pharmacists Canadian Generic Pharmaceutical Association Canada s Research-based Pharmaceutical Companies Canadian Association of Chain Drug Stores Canadian Association for Pharmacy Distribution Management Selected Group (Public) Contracting Organizations GS1 Canada Health Canada (Observer)

PRACTICE ENDORSEMENTS TECHNICAL GUIDELIUNES Progressive Practice Integration

Project Structure & Flow (Phase II) (Phase III) (Phase IV)

The Voluntary Joint Technical Statement (2010) Section 1: Pharmaceuticals to be Encoded Section 2: A National Automated Identification Standard Section 3: Content of the Bar Codes Section 4: Pharmaceutical Packaging Levels and Placement of Bar Codes Section 5: A Common Canadian Pharmaceutical Product Registry (CCPPR) Section 6: Bar Code Symbologies Section 7: Expectations of Professional Practice Organizations and End-Users Section 8: Timeline Adoption of Standard (Pharmaceuticals Dec 2012)

Health Organization Formal Endorsements Key Canadian Organizations have endorsed our Strategy, including: Canada Health Council Canadian Healthcare Association Canadian Medical Association Canadian Nursing Association Canadian Society of Hospital Pharmacists Healthcare Insurance Reciprocal of Canada (HIROC) Ontario Hospital Association 3 Provincial Health Quality Councils (AB, BC, and MB)

Selected International Recommendations for Bar Coded Medications and Systems US: The Council recommends that health care organizations employ machine-readable systems (e.g., bar coding) in the management of the medication use process. National Coordinating Council for Medication Error Reporting and Prevention, 2007 (U.S.) US: The use of bar coding in several hospitals has shown that the system can significantly diminish medication errors. Lester Crawford, Deputy Commissioner, FDA, 2002 UK: The case for [bar] coding is compelling, but all stakeholders need to work to commonly agreed standards if the benefits are to be realised fully. UK NHS Department of Health: Coding for Success, 2007 Australia: TGC notes: That inclusion of bar codes on medicines has potential to improve patient safety through reducing dispensing errors. Agrees: That consideration of mandatory bar coding requirements for medicines should be given high priority. Therapeutics Goods Committee, Dept of Health and Ageing, Australian Government,2008

How will the standardized bar coding integrate into professional practices?

Practice Implementation

A Safe Medication Chain

Canadian Bar Coding Key Points Medication error rates are too high. The public and health professionals are concerned. Evidence shows many errors are preventable through medication bar coding and related patient care system improvements. Other international health jurisdictions have embraced medication label bar coding requirements as a critical first step toward improved public safety. ISMP Canada and CPSI have facilitated a collaborative strategy with over 50 participating organizations to address the technical approach to bar coding, adopting a common global standard (GS1). Health Canada companion regulations, with practice support from Provincial and Territorial health ministries, can improve public medication safety, in a cost-effective manner.

Future Discussion Opportunities Support for Health Canada companion regulations for pharmaceutical automated identification (e.g. bar code). Reference to the Canadian Pharmaceutical Bar Coding Strategy and the Joint Technical Statement on Canadian Pharmaceutical Automated Identification and Product Data Requirements, within Health Canada guidance documents to manufacturers. Advice on how best to move this collaborative strategy forward, with an opportunity for continued dialogue and a report back to the FPT Deputy Ministers Committee. Support from Provincial and Territorial Health Ministries to promote automated identification knowledge transfer and practice integration as a key patient safety priority. Release funds to support future trials and implementation of medication automated identification practices, within both institutional and community care environments.

Thank You